20/20 Biolabs, Inc.
No trades
−3.74 M USD
2.05 M USD
6.95 M
About 20/20 Biolabs, Inc.
Sector
Industry
CEO
Jonathan Cohen
Website
Headquarters
Gaithersburg
Founded
2000
IPO date
Feb 19, 2026
Identifiers
3
ISIN US90138K1016
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of AIDX is 1.46 USD — it has increased by 6.33% in the past 24 hours. Watch 20/20 Biolabs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 20/20 Biolabs, Inc. stocks are traded under the ticker AIDX.
AIDX stock has fallen by −2.23% compared to the previous week, the month change is a −20.40% fall, over the last year 20/20 Biolabs, Inc. has showed a −97.09% decrease.
AIDX reached its all-time high on Feb 19, 2026 with the price of 50.00 USD, and its all-time low was 1.32 USD and was reached on May 8, 2026. View more price dynamics on AIDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AIDX stock is 21.17% volatile and has beta coefficient of 3.72. Track 20/20 Biolabs, Inc. stock price on the chart and check out the list of the most volatile stocks — is 20/20 Biolabs, Inc. there?
Yes, you can track 20/20 Biolabs, Inc. financials in yearly and quarterly reports right on TradingView.
AIDX net income for the last quarter is −1.31 M USD, while the quarter before that showed −825.54 K USD of net income which accounts for 0.00% change. Track more 20/20 Biolabs, Inc. financial stats to get the full picture.
No, AIDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 13, 2026, the company has 14 employees. See our rating of the largest employees — is 20/20 Biolabs, Inc. on this list?
Like other stocks, AIDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 20/20 Biolabs, Inc. stock right from TradingView charts — choose your broker and connect to your account.